Research evidence shows that gastrointestinal (GI) tract hormones incretins may play a vital role in the pathogenesis and treatment of obesity and its comorbidities, as they are responsible for the regulation of body weight, maintenance of energy balance, and glucose homeostasis [6,7,8,9]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.